Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Veeva Systems Inc. (VEEV) Stock Forecast & Price Prediction United States | NYSE | Healthcare | Health Information Services
$167.79
-1.05 (-0.62%)Did VEEV Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Veeva is one of their latest high-conviction picks.
Based on our analysis of 48 Wall Street analysts, VEEV has a bullish consensus with a median price target of $275.00 (ranging from $176.00 to $350.00). The overall analyst rating is Strong Buy (8.2/10). Currently trading at $167.79, the median forecast implies a 63.9% upside. This outlook is supported by 22 Buy, 8 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Stan Zlotsky at Morgan Stanley, projecting a 108.6% upside. Conversely, the most conservative target is provided by Tyler Radke at Citigroup, suggesting a 4.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for VEEV.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 10, 2026 | Citigroup | Tyler Radke | Neutral | Downgrade | $176.00 |
| Mar 9, 2026 | Citigroup | Tyler Radke | Buy | Maintains | $291.00 |
| Mar 5, 2026 | Canaccord Genuity | David Hynes | Hold | Maintains | $235.00 |
| Mar 5, 2026 | Morgan Stanley | Craig Hettenbach | Equal-Weight | Maintains | $215.00 |
| Mar 5, 2026 | Truist Securities | Jailendra Singh | Buy | Reiterates | $262.00 |
| Mar 5, 2026 | Wells Fargo | Stan Berenshteyn | Overweight | Maintains | $317.00 |
| Mar 5, 2026 | Evercore ISI Group | Kirk Materne | In-Line | Maintains | $240.00 |
| Mar 5, 2026 | Piper Sandler | Hannah Rudoff | Overweight | Maintains | $285.00 |
| Mar 5, 2026 | UBS | Karl Keirstead | Neutral | Maintains | $220.00 |
| Mar 5, 2026 | Stifel | David Grossman | Buy | Maintains | $245.00 |
| Mar 5, 2026 | Needham | Ryan MacDonald | Buy | Maintains | $270.00 |
| Mar 5, 2026 | TD Cowen | Charles Rhyee | Buy | Maintains | $300.00 |
| Mar 5, 2026 | RBC Capital | Rishi Jaluria | Outperform | Maintains | $275.00 |
| Feb 26, 2026 | Stifel | David Grossman | Buy | Maintains | $212.00 |
| Feb 25, 2026 | Barclays | Saket Kalia | Overweight | Maintains | $250.00 |
| Feb 24, 2026 | Oppenheimer | Ken Wong | Outperform | Maintains | $275.00 |
| Feb 20, 2026 | JP Morgan | Alexei Gogolev | Overweight | Maintains | $296.00 |
| Feb 20, 2026 | UBS | Karl Keirstead | Neutral | Maintains | $200.00 |
| Feb 17, 2026 | Morgan Stanley | Craig Hettenbach | Equal-Weight | Upgrade | $205.00 |
| Dec 12, 2025 | Keybanc | Scott Schoenhaus | Sector Weight | Downgrade | $N/A |
The following stocks are similar to Veeva based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Veeva Systems Inc. has a market capitalization of $27.58B with a P/E ratio of 30.8x. The company generates $3.20B in trailing twelve-month revenue with a 28.4% profit margin.
Revenue growth is +16.0% quarter-over-quarter, while maintaining an operating margin of +29.4% and return on equity of +13.9%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides cloud solutions for the life sciences industry.
Veeva Systems generates revenue by offering cloud-based software, data solutions, and consulting services specifically designed for the life sciences sector. Their flagship products, Veeva CRM and Veeva Vault, facilitate various business functions, including sales, marketing, and regulatory compliance, allowing clients to enhance productivity while ensuring adherence to industry regulations.
Founded in 2007 and headquartered in Pleasanton, California, Veeva operates globally, serving clients across North America, Europe, Asia Pacific, and Latin America. As a Public Benefit Corporation, it focuses on leveraging modern cloud architecture to replace outdated systems, which positions the company for continuous growth and innovation in a rapidly evolving market.
Healthcare
Health Information Services
7,928
Mr. Peter P. Gassner
United States
2013
OPRX's rising cash flow, DAAP adoption and expanding pharma ties boost outlook despite near-term revenue softness and cautious client spending.
OptimizeRx trades at a steep discount to peers, but strong AI-driven growth, rising cash flow and DAAP traction look encouraging.
Veeva (VEEV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Analyst recommendations from brokerage firms can significantly impact stock prices, influencing investors' decisions to buy, sell, or hold shares.
Analyst recommendations can significantly impact stock prices, influencing investor sentiment and trading decisions. Changes in ratings may lead to increased volatility and trading volume.
Michael Burry, known for his short bet against the housing market in 2008, has recently made headlines by taking long stock positions.
Michael Burry's long stock positions signal a potential shift in market sentiment, indicating confidence in specific stocks or sectors, which could influence investor strategies and market trends.
Veeva (VEEV) has been upgraded to a Zacks Rank #1 (Strong Buy), indicating improved earnings outlook and potential for stock price increase.
Veeva's upgrade to a Zacks Rank #1 signals strong earnings potential, likely boosting investor confidence and driving the stock price upward.
Michael Burry, known for 'The Big Short,' remains active in the stock market despite Scion Asset Management's deregistration in late 2025, revealing three new long positions on April 13.
Michael Burry's new long positions signal potential market opportunities, indicating his confidence in specific stocks despite the deregistration, which may influence investor sentiment.
Veeva (VEEV) is currently oversold, suggesting reduced selling pressure. Analysts are also raising earnings estimates, indicating a potential trend reversal.
Veeva's oversold status suggests reduced selling pressure, while rising earnings estimates from analysts point to a potential price rebound, signaling a favorable investment opportunity.
Veeva (VEEV) is gaining attention from Zacks.com users, indicating potential interest that could influence the stock's future performance.
Increased attention from Zacks.com users may signal heightened interest and potential volatility in Veeva's stock, impacting trading strategies and investment decisions.
Based on our analysis of 48 Wall Street analysts, Veeva Systems Inc. (VEEV) has a median price target of $275.00. The highest price target is $350.00 and the lowest is $176.00.
According to current analyst ratings, VEEV has 22 Buy ratings, 8 Hold ratings, and 1 Sell ratings. The stock is currently trading at $167.79. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict VEEV stock could reach $275.00 in the next 12 months. This represents a 63.9% increase from the current price of $167.79. Please note that this is a projection by Wall Street analysts and not a guarantee.
Veeva Systems generates revenue by offering cloud-based software, data solutions, and consulting services specifically designed for the life sciences sector. Their flagship products, Veeva CRM and Veeva Vault, facilitate various business functions, including sales, marketing, and regulatory compliance, allowing clients to enhance productivity while ensuring adherence to industry regulations.
The highest price target for VEEV is $350.00 from Stan Zlotsky at Morgan Stanley, which represents a 108.6% increase from the current price of $167.79.
The lowest price target for VEEV is $176.00 from Tyler Radke at Citigroup, which represents a 4.9% increase from the current price of $167.79.
The overall analyst consensus for VEEV is bullish. Out of 48 Wall Street analysts, 22 rate it as Buy, 8 as Hold, and 1 as Sell, with a median price target of $275.00.
Stock price projections, including those for Veeva Systems Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.